SciSight Ecosystem
WoS SCIE Q3Scopus Q2SCImago #5,061CAS 3区Top JournalReview JournalHybrid

Current Opinion in Oncology

Abbreviation (ISO):CURR OPIN ONCOL
Country: United States•WoS SCIE Quartile: Q3•Scopus SJR: 0.979•SCImago Rank: #5,061•Identifier (ISSN):1040-8746(Print)/1531-703X(Online)•Articles / Year: 88•Estimated Publication Fee (APC): $3,340 USD
Clarivate IF (2026)Q3
2.4
– 0

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
86

86 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
88articles/year
12.6% Gold OA•0% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 2.4)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 2.4)
🔵 Computed
20251.50đ
WoS Q3(IF: 2.4)
🔵 Computed
20241.50đ
WoS Q3(IF: 2.8)
🔵 Computed
20231.50đ
WoS Q3(IF: 3.4)
🔵 Computed
20221.50đ
WoS Q3(IF: 3.915)
🔵 Computed
20211.50đ
WoS Q3(IF: 3.645)
🔵 Computed
20201.50đ
WoS Q3(IF: 3.336)
🔵 Computed
20191.50đ
WoS Q3(IF: 3.261)
🔵 Computed
20181.50đ
WoS Q3(IF: 3.653)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

With its easy-to-digest reviews on important advances in world literature, Current Opinion in Oncology offers expert evaluation on a wide range of topics from sixteen key disciplines including sarcomas, cancer biology, melanoma and endocrine tumors. Published bimonthly, each issue covers in detail the most pertinent advances in these fields from the previous year. This is supplemented by annotated references detailing the merits of the most important papers.

Topics Covered (Recognized by AI)
Medicine98.6%Biology85.4%Internal medicine80.5%Genetics73%Pathology54.4%Cancer50.1%Oncology45.3%Surgery41.5%Chemistry38%Biochemistry35.2%Immunology32.4%Cancer research29.2%Radiology23.3%Chemotherapy21.1%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,061Scopus Q2SCImago Profile
Scopus Coverage:1989-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.979

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
108

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.43

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,340 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations727
3-Year Documents274
Citable Documents253

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate38.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ2
OncologyQ2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
1989
Editorial Address
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
214/333Q3
ONCOLOGY
JCISCIE
271/333Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—6013
20252.489189
20242.896467
20233.484586
20223.9151031,058
20213.645971,244
20203.336931,976
20193.2611052,725
20183.653641,339
2017—732,623
2016—852,135
2015—912,564
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Current Opinion in Oncology

WoS Q3
1245201820192020202120222023202420252.40
Annual Impact Factor Metric
2025:2.4

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 87867ca9-7080-4aa6-8a5e-a5233405bd7a
Database Updated: 2026-09-28